🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 80% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
78 Servings
Other Combinations Product Type
80% Evidence Coverage

Supplement Facts — Evidence Check

5 mg (25% DV)
✅ Within RDA (0.4× RDA of 14 mg) 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 5mg UL 35mg
3 mg (150% DV)
✅ 2.3× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 3mg UL 100mg
250 mcg (4167% DV)
📊 104.2× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.25mg
134 mcg (112% DV)
📊 3.8× RDA — above typical dose 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.134mg
PX9(TM) Ballistic Beadlet Complex
224 mg

Other Ingredients

Gelatin Microcrystalline Cellulose Ethylcellulose Hypromellose Magnesium Stearate Talc Xylitol Medium Chain Triglycerides Titanium Dioxide FD&C Yellow #5 Aluminum Lake Stearic Acid Sodium Alginate

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

SUGGESTED USE: As a dietary supplement, adults begin by taking one serving (1 capsule) 30 minutes before breakfast, lunch and dinner. Do not exceed three servings per day. Please read the entire label before use.

⚠️ Warnings & Precautions

CONTAINS: Soy.

WARNING: DO NOT USE IF PREGNANT, PLANNING PREGNANCY, OR NURSING.

KEEP OUT OF REACH OF CHILDREN.

THIS PRODUCT IS ONLY INTENDED TO BE CONSUMED BY HEALTHY ADULTS, 18 YEARS OF AGE OR OLDER. Consult with your physician before using this product. Discontinue use and consult a health care professional if you experience any adverse reaction to this product. Use only as directed. Discontinue use two weeks prior to surgery. Do not exceed recommended daily intake. DO NOT USE IF SAFETY SEAL UNDER CAP IS BROKEN.

🧪 Formulation Notes

This advanced ingredient formulation includes three patented ingredients — Capsimax(R), GreenSelect(R) Phytosome(R) and Zychrome(R) — all in dosages shown to be effective in preliminary clinical research.*

CONTAINS: Soy.

Zychrome(R) is provided in the clinical dosage of 400 mcg chromium dinicocysteinate daily.*

POWERED BY: CX2(TM) Thermogenic Activator* contains award-winning Capsimax(R), which induces thermogenesis with the hot natural capsicum fruit extract from red hot peppers without the burn.

GreenSelect(R) Phytosome(R) is a caffeine-free proprietary extract of green tea leaves.

GreenSelect(R) Phytosome(R) is a caffeine-free proprietary extract of green tea leaves.

Additional Information

HARD HITTING WEIGHT LOSS WITHOUT UNNECESSARY STIMULATION.1 PERFORMIX STIMFREE is a revolutionary weight loss activator1 with clinically proven key ingredients.*

TERRA INTELLIGENT DOSING(TM)

FAT LOSS APPETITE MANAGEMENT POSITIVE MOOD

MULTI-PHASE EXTENDED RELEASE BEADLETS

Protect from heat and freezing. Do not expose to direct sunlight or leave in vehicle exposed to sunlight. Store in a cool (60-80°F), dry place.

Please recycle

{Recycle}

Capsimax(R)

PHOTOSOME

ZyChrome

When used in conjunction with a calorie-reduced diet and regular exercise program.

MADE IN THE USA

Proudly made in the USA with carefully selected ingredients of international and domestic origin.

cGMP GOOD MANUFACTURING PRACTICE QUALITY PRODUCT

ITEM 134 1.1

The clinical dosage of 300 mg daily has been shown in studies to support weight loss (an average of 30.86 lbs in 90 days versus 11 lbs in the diet-only group).1*

Product Details

UPC / SKU 8 11274 02006 5
DSLD Entry Date 2015-03-25
Product Type Other Combinations
Form Capsule
Brand Performix
DSLD ID 43385
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →